{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:07Z","timestamp":1786123207952,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1213\/ane.0000000000000374","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T07:14:50Z","timestamp":1405667690000},"page":"619-626","source":"Crossref","is-referenced-by-count":54,"title":["Hydroxyethyl Starch and Acute Kidney Injury in Orthotopic Liver Transplantation"],"prefix":"10.1213","volume":"120","author":[{"given":"William R.","family":"Hand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom I.","family":"Epperson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Crego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Chavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Taber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210902","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/lt.21682","article-title":"Acute kidney injury following liver transplantation: definition and outcome.","volume":"15","author":"Barri","year":"2009","journal-title":"Liver Transpl"},{"key":"R2-20-20210902","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R3-20-20210902","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8.4","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R4-20-20210902","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5002743","article-title":"The RIFLE criteria and mortality in acute kidney injury: a systematic review.","volume":"73","author":"Ricci","year":"2008","journal-title":"Kidney Int"},{"key":"R5-20-20210902","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-6143.2006.01602.x","article-title":"Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation.","volume":"7","author":"O\u2019Riordan","year":"2007","journal-title":"Am J Transplant"},{"key":"R6-20-20210902","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"R7-20-20210902","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8278(00)80423-7","article-title":"Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.","volume":"32","author":"Arroyo","year":"2000","journal-title":"J Hepatol"},{"key":"R8-20-20210902","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jlts.2002.31516","article-title":"Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.","volume":"8","author":"Davis","year":"2002","journal-title":"Liver Transpl"},{"key":"R9-20-20210902","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1081\/JDI-120022546","article-title":"Risk factors for development of acute renal failure after liver transplantation.","volume":"25","author":"Lima","year":"2003","journal-title":"Ren Fail"},{"key":"R10-20-20210902","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1399-0012.2003.00132.x","article-title":"Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease.","volume":"18","author":"Paramesh","year":"2004","journal-title":"Clin Transplant"},{"key":"R11-20-20210902","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients.","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"R12-20-20210902","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00003246-199901000-00025","article-title":"Distribution of normal saline and 5% albumin infusions in septic patients.","volume":"27","author":"Ernest","year":"1999","journal-title":"Crit Care Med"},{"key":"R13-20-20210902","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential.","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"key":"R14-20-20210902","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"R15-20-20210902","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit.","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"R16-20-20210902","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care.","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-20-20210902","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis.","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"R19-20-20210902","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1213\/ANE.0b013e3182099c49","article-title":"Hydroxyethyl starches: what do we still know?","volume":"112","author":"Reinhart","year":"2011","journal-title":"Anesth Analg"},{"key":"R20-20-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e31820ad3b7","article-title":"Shadow of doubt.","volume":"112","author":"Shafer","year":"2011","journal-title":"Anesth Analg"},{"key":"R21-20-20210902","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/pds.1674","article-title":"Assessing balance in measured baseline covariates when using many-to-one matching on the propensity score.","volume":"17","author":"Ausin","year":"2008","journal-title":"Pharamcoepidemiol Drug Saf"},{"key":"R22-20-20210902","first-page":"1","article-title":"Multivariate Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R.","volume":"42.7","author":"Sekhon","year":"2011","journal-title":"J Stat Soft"},{"key":"R24-20-20210902","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/ane.0b013e3181aed54f","article-title":"The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.","volume":"109","author":"Mukhtar","year":"2009","journal-title":"Anesth Analg"},{"key":"R25-20-20210902","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis.","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"R26-20-20210902","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc8920","article-title":"Resuscitation with low volume hydroxyethylstarch 130 kDa\/0.4 is not associated with acute kidney injury.","volume":"14","author":"Boussekey","year":"2010","journal-title":"Crit Care"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:19Z","timestamp":1786112599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201503000-00020"}},"subtitle":["A Single-Center Retrospective Review"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000374","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}